文献速递消化道肿瘤与早癌

识别Wnt驱动的长链非编码转录组中结直肠癌特异性脆弱点

Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome.
PubMed 文献 · Gut · 2025-03-06

研究通过全基因组run-on测序定义结直肠癌中β-catenin调控的长链非编码RNA,并用CRISPRi dropout筛选确定其功能相关性。发现LINC02418对癌细胞克隆形成至关重要,通过调控MYC表达促进干性并阻止终末分化。开发了靶向LINC02418的siRNA疗法并在体内验证有效,提出癌症特异性Wnt调控lncRNA可作为治疗新机会。

要点

  • 全基因组run-on测序揭示结直肠癌中β-catenin调控的lncRNA谱。
  • LINC02418为癌细胞克隆形成所必需,通过调控MYC表达维持干性。
  • 靶向LINC02418的siRNA疗法在体内有效,为Wnt通路提供新治疗策略。

核心结论

  • 癌症特异性Wnt调控lncRNA为干预Wnt通路提供了新的治疗机会。

研究设计与样本

  • 研究采用全基因组run-on测序定义结直肠癌中β-catenin调控的lncRNA。
  • 随后用CRISPRi dropout筛选建立部分lncRNA对结直肠癌长期扩增的功能相关性。

主要发现

  • LINC02418对癌细胞克隆形成至关重要。
  • LINC02418调控MYC表达水平以促进结直肠癌干细胞功能并阻止终末分化。
  • 开发了有效的siRNA疗法在体内靶向LINC02418 RNA。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aberrant Wnt pathway activation is a key driver of colorectal cancer (CRC) and is essential to sustain tumour growth and progression. Although the downstream protein-coding target genes of the Wnt cascade are well known, the long non-coding transcriptome has not yet been fully resolved. OBJECTIVE: In this study, we aim to comprehensively reveal the Wnt-regulated long non-coding transcriptome and exploit essential molecules as novel therapeutic targets. DESIGN: We used global run-on sequencing to define β-catenin-regulated long non-coding RNAs (lncRNAs) in CRC. CRISPRi dropout screens were subsequently used to establish the functional relevance of a subset of these lncRNAs for long-term expansion of CRC. RESULTS: We uncovered that LINC02418 is essential for cancer cell clonogenic outgrowth. Mechanistically, LINC02418 regulates MYC expression levels to promote CRC stem cell functionality and prevent terminal differentiation. Furthermore, we developed effective small interfering RNA (siRNA)-based therapeutics to target LINC02418 RNA in vivo. CONCLUSION: We propose that cancer-specific Wnt-regulated lncRNAs provide novel therapeutic opportunities to interfere with the Wnt pathway, which has so far defied effective pharmacological inhibition.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Schwarzmueller LJ, Adam RS, Moreno LF, et al. Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome. Gut. 2025. PMID: 39562049. doi:10.1136/gutjnl-2024-332752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。